Abstract
Co-infection of HCV with HIV has been associated with more rapid progression of HCV-related disease. HCV-specific T-cell immune responses, which are essential for disease control, are attenuated in co-infection with HIV. T-cell exhaustion has recently been implicated in the deficient control of chronic viral infections. In the current study, we investigated the role of programmed death-1 (PD-1) and T-cell immunoglobulin and mucin domain-containing molecule-3 (Tim-3) expression in T-cell exhaustion during HCV/HIV co-infection. We show that in HCV/HIV co-infection, both total and HCV-specific T cells co-express Tim-3 and PD-1 in significantly higher frequencies, compared with HCV mono-infection. Co-expression of these two markers on HCV-specific CD8(+) T cells positively correlated with a clinical parameter of liver disease progression. HCV-specific CD8(+) T cells showed greater frequencies of Tim-3/PD-1 co-expression than HIV-specific CD8(+) T cells, which may indicate a greater degree of exhaustion in the former. Blocking Tim-3 or PD-1 pathways restored both HIV- and HCV-specific CD8(+) T-cell expansion in the blood of co-infected individuals. These data demonstrate that co-expression of Tim-3 and PD-1 may play a significant role in HCV-specific T-cell dysfunction, especially in the setting of HIV co-infection.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Blocking / pharmacology
-
Antigens, CD / genetics
-
Antigens, CD / immunology
-
Antigens, CD / metabolism*
-
Antigens, Viral / immunology
-
Apoptosis Regulatory Proteins / genetics
-
Apoptosis Regulatory Proteins / immunology
-
Apoptosis Regulatory Proteins / metabolism*
-
CD8-Positive T-Lymphocytes / immunology
-
CD8-Positive T-Lymphocytes / metabolism*
-
CD8-Positive T-Lymphocytes / pathology
-
CD8-Positive T-Lymphocytes / virology
-
Cell Proliferation / drug effects
-
Cell Separation
-
Cells, Cultured
-
Disease Progression
-
Female
-
Flow Cytometry
-
HIV Infections / complications
-
HIV Infections / immunology*
-
HIV Infections / pathology
-
HIV Infections / physiopathology
-
HIV-1 / immunology*
-
HIV-1 / pathogenicity
-
HLA-A Antigens / immunology
-
HLA-A Antigens / metabolism
-
HLA-A2 Antigen
-
Hepacivirus / immunology*
-
Hepacivirus / pathogenicity
-
Hepatitis A Virus Cellular Receptor 2
-
Hepatitis C / complications
-
Hepatitis C / immunology*
-
Hepatitis C / pathology
-
Hepatitis C / physiopathology
-
Humans
-
Liver / immunology
-
Liver / pathology
-
Liver / virology
-
Male
-
Membrane Proteins / genetics
-
Membrane Proteins / immunology
-
Membrane Proteins / metabolism*
-
Programmed Cell Death 1 Receptor
Substances
-
Antibodies, Blocking
-
Antigens, CD
-
Antigens, Viral
-
Apoptosis Regulatory Proteins
-
HAVCR2 protein, human
-
HLA-A Antigens
-
HLA-A*02:01 antigen
-
HLA-A2 Antigen
-
Hepatitis A Virus Cellular Receptor 2
-
Membrane Proteins
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor